Physicians Realty Trust of Beneficial Interest (DOC) Financials

$20.74

$-0.08 (-0.41%)

As on 04-Sep-2026 13:41EDT

Market cap

$14,909 Mln

Revenue (TTM)

$2,950 Mln

P/E Ratio

60.1

P/B Ratio

1.8

Div. Yield

5.8 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	2,949.81	2,822.51	2,700.45	2,181.00	2,061.18	1,896.18
Cost of Revenue	2,875.09	2,187.96	1,074.86	902.06	862.99	773.28
Gross Profit	74.71	634.55	1,625.59	1,278.94	1,198.19	1,122.91
Operating Expenses	-444.75	90.42	1,154.37	845.03	841.60	782.59
Operating Profit (EBIT)	519.46	544.13	471.22	433.91	356.59	340.32
Other Income	--	--	--	--	--	--
Profit before Tax	278.51	110.31	271.65	325.14	509.12	134.47
Provision for Tax	3.67	9.28	4.35	-9.62	-4.43	-3.26
Profit after Tax (Net Income)	253.72	71.35	243.14	306.01	500.45	505.54
Minority Interest	-31.54	-29.68	-24.16	-28.57	-15.98	-20.39
Consolidated Profit	-3.41	70.51	242.38	304.28	497.79	502.27

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	7,844.75	7,500.09	8,401.28	6,350.45	6,654.70	6,515.47
Minority Interest	-31.54	--	--	--	--	--
Non-Current Liabilities	11,431.16	11,048.26	10,005.29	7,396.06	6,710.79	6,175.00
Current Liabilities	750.45	985.31	875.34	1,377.93	1,772.16	1,936.42
Total Liabilities	22,430.49	20,336.02	19,938.26	15,698.85	15,771.23	15,257.52

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	1,303.47	1,246.49	18,952.11	15,137.57	15,166.26	14,544.09
Current Assets	1,888.23	1,073.48	986.15	561.28	604.97	713.43
Total Assets	23,654.23	20,336.02	19,938.26	15,698.85	15,771.23	15,257.52
Total Debt*	10,320.38	10,440.41	9,023.27	7,083.04	6,706.13	6,374.54
Net Current Assets	-85.96	-506.59	110.80	-816.65	-1,167.19	-1,222.98

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	1,251.96	1,070.50	956.24	900.26	795.25
Cash Flow from Investing Activities	--	-1,034.67	-113.80	-576.75	-876.34	531.03
Cash from Financing Activities	--	136.11	-941.42	-337.30	-116.53	-1,288.52
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	0.37	0.10	0.35	0.56	0.93	0.94
Cash EPS ($)	0.35	1.57	1.86	1.91	2.25	2.21
Adjusted Book Value ($)	11.38	10.78	12.01	11.60	12.36	12.08
Dividend per Share ($)	5.80	--	--	--	--	--
Cash Flow per Share ($)	--	1.80	1.53	1.75	1.67	1.47
Free Cash Flow per Share ($)	--	1.80	1.53	1.75	1.47	1.47

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	0.40	1.58	2.28	3.81	3.87
ROE (%)	2.90	0.90	3.30	4.71	7.60	7.63
ROA (%)	1.13	0.35	1.36	1.94	3.23	3.24
EBIT Margin (%)	23.23	14.72	20.50	23.63	32.99	15.10
Net Margin (%)	8.60	2.53	9.00	14.03	24.28	26.66
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	5.52	0.05	0.24	0.06	0.09	0.15
EBIT Growth (%)	42.28	-24.95	7.44	-24.23	137.50	-34.33
Net Profit Growth (%)	61.76	-70.66	-20.54	-38.85	-1.01	22.24
EPS Growth (%)	55.09	-0.71	-0.38	-0.40	-0.01	0.22
Book Value Growth (%)	-0.01	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	60.09	156.87	58.32	23.81	15.57	20.10
Price / Book Value	1.83	1.49	1.69	1.15	1.17	1.56
Dividend Yield (%)	5.80	--	--	--	--	--
EV/EBITDA	12.26	14.31	14.33	11.25	10.37	16.87
Close Price ($)	21.40	16.08	20.27	13.31	14.47	18.83
High Price ($)	21.91	21.28	23.26	16.34	19.12	19.59
Low Price ($)	15.71	15.71	10.78	10.52	13.42	16.57
Market Cap ($ Cr)	14,909.16	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	1.09	1.39	1.07	1.12	1.01	0.98
Short term debt to equity ratio	0.10	0.13	0.02	0.11	0.15	0.18
Current Ratio	2.52	1.09	1.13	0.41	0.34	0.37
Quick Ratio	2.52	--	--	-0.04	0.35	0.37
Interest Coverage	1.83	1.36	1.97	2.57	3.93	1.81

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	8.86	24.25	29.40	12.58	20.78	24.50
Asset Turnover	0.13	0.14	0.15	0.14	0.13	0.12
Receivable days	--	95.65	72.24	58.83	79.10	67.62
Inventory Days	--	--	208.19	121.49	-2.25	-2.11
Payable days	--	83.01	87.71	102.41	104.38	117.33
Cash Conversion Cycle	--	--	192.73	77.91	-27.52	-51.81

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)